Home
About
Services
Partners
Client Portfolio
News
Contact
Exclusive: Pershing Square’s Ackman eyes $1 billion-plus ‘blank-check’ company – sources
June 11, 2020
Oil prices set for worst daily drop since April on inventories, bearish Fed
June 11, 2020
0
Japan’s Takeda to sell some Asia-focused drugs to Celltrion for $278 million
Published by
Muller&Green
at
June 11, 2020
Categories
RSS
Tags
Takeda Pharmaceutical Co Ltd has agreed to sell a portfolio of over-the-counter and prescription drugs marketed in the Asia Pacific region to South Korea’s Celltrion Inc for $278 million, it said on Thursday
Powered by
WPeMatico
Muller&Green
Related posts
February 8, 2025
Recent Aviation Disasters Cause Fears About the Safety of Flying
Read more
February 8, 2025
What Whiplash U.S. Climate Policy Means for Business
Read more
February 8, 2025
Here’s Where China’s Retaliatory Tariffs on the U.S. Could Hit Hardest
Read more